In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
106 News Items found
Luc Morris
New AI Tool Uses Routine Blood Tests To Predict Immunotherapy Response for Many Cancers

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.
Woman examining her face for signs of cancer
Feature
Five Things to Know If You've Been Diagnosed with Skin Cancer on Your Face

Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.
Doctors operating
New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Physician-scientist Luc Morris
In the Lab
Clearing the Fog around Tumor Mutational Burden

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.